Shinde V, Lombard Koen A, Hoosain Z, Archary M, Bhorat Q, Fairlie L
Hum Vaccin Immunother. 2024; 20(1):2425147.
PMID: 39666396
PMC: 11789733.
DOI: 10.1080/21645515.2024.2425147.
Tschiderer L, Innerhofer H, Seekircher L, Waltle L, Richter L, Kimpel J
iScience. 2024; 27(11):111117.
PMID: 39555399
PMC: 11567098.
DOI: 10.1016/j.isci.2024.111117.
Hu Y, Wu Q, Chang F, Yang J, Zhang X, Wang Q
NPJ Vaccines. 2024; 9(1):195.
PMID: 39438493
PMC: 11496711.
DOI: 10.1038/s41541-024-00997-8.
Odle A, Kar M, Verma A, Sariol A, Meyerholz D, Suthar M
JCI Insight. 2024; 9(23).
PMID: 39405115
PMC: 11623939.
DOI: 10.1172/jci.insight.184074.
Alirezaylavasani A, Skeie L, Egner I, Chopra A, Dahl T, Prebensen C
NPJ Vaccines. 2024; 9(1):185.
PMID: 39384763
PMC: 11464709.
DOI: 10.1038/s41541-024-00972-3.
COVID-19 Vaccination Hesitancy among the General Population: A Gender-Based Review and Bibliometric Analysis.
Panda M, Kundapur R, Kamble B
Arch Razi Inst. 2024; 79(1):33-40.
PMID: 39192962
PMC: 11345477.
DOI: 10.32592/ARI.2024.79.1.33.
Mathematical Modeling of SARS-CoV-2 Omicron Wave under Vaccination Effects.
Gonzalez-Parra G, Arenas A
Computation (Basel). 2024; 11(2).
PMID: 38957648
PMC: 11218807.
DOI: 10.3390/computation11020036.
Non-cross-reactive epitopes dominate the humoral immune response to COVID-19 vaccination - kinetics of plasma antibodies, plasmablasts and memory B cells.
Wietschel K, Fechtner K, Antileo E, Abdurrahman G, Drechsler C, Makuvise M
Front Immunol. 2024; 15:1382911.
PMID: 38807606
PMC: 11130424.
DOI: 10.3389/fimmu.2024.1382911.
Comparative Analysis of Vaccine-Induced Neutralizing Antibodies against the Alpha, Beta, Delta, and Omicron Variants of SARS-CoV-2.
Girl P, von Buttlar H, Mantel E, Antwerpen M, Wolfel R, Muller K
Vaccines (Basel). 2024; 12(5).
PMID: 38793766
PMC: 11126034.
DOI: 10.3390/vaccines12050515.
Immunogenicity of COVID-19 booster vaccination in IEI patients and their one year clinical follow-up after start of the COVID-19 vaccination program.
van Leeuwen L, Grobben M, GeurtsvanKessel C, Ellerbroek P, de Bree G, Potjewijd J
Front Immunol. 2024; 15:1390022.
PMID: 38698851
PMC: 11063285.
DOI: 10.3389/fimmu.2024.1390022.
A chimeric adenovirus-vectored vaccine based on Beta spike and Delta RBD confers a broad-spectrum neutralization against Omicron-included SARS-CoV-2 variants.
Hong W, Lei H, Peng D, Huang Y, He C, Yang J
MedComm (2020). 2024; 5(5):e539.
PMID: 38680520
PMC: 11055958.
DOI: 10.1002/mco2.539.
Mucosal Vaccination with a Newcastle Disease Virus-Vectored Vaccine Reduces Viral Loads in SARS-CoV-2-Infected Cynomolgus Macaques.
Warner B, Chan M, Tailor N, Vendramelli R, Audet J, Meilleur C
Vaccines (Basel). 2024; 12(4).
PMID: 38675786
PMC: 11054841.
DOI: 10.3390/vaccines12040404.
SARS-CoV-2 IgG Levels as Predictors of XBB Variant Neutralization, Israel, 2022- and 2023.
Lustig Y, Canetti M, Indenbaum V, Peretz Y, Weiss-Ottolenghi Y, Margalit I
Emerg Infect Dis. 2024; 30(5):1050-1052.
PMID: 38666742
PMC: 11060444.
DOI: 10.3201/eid3005.231739.
An ancestral SARS-CoV-2 vaccine induces anti-Omicron variants antibodies by hypermutation.
Park S, Choi J, Lee Y, Noh J, Kim N, Lee J
Nat Commun. 2024; 15(1):3368.
PMID: 38643233
PMC: 11032360.
DOI: 10.1038/s41467-024-47743-1.
Immunogenicity and safety of a recombinant COVID-19 vaccine (ZF2001) as heterologous booster after priming with inactivated vaccine in healthy children and adolescents aged 3-17 years: an open-labeled, single-arm clinical trial.
Huang T, Hu Q, Zhou X, Yang H, Xia W, Cao F
BMC Infect Dis. 2024; 24(1):413.
PMID: 38641791
PMC: 11027523.
DOI: 10.1186/s12879-024-09293-1.
SARS-CoV-2 journey: from alpha variant to omicron and its sub-variants.
Hattab D, Amer M, Al-Alami Z, Bakhtiar A
Infection. 2024; 52(3):767-786.
PMID: 38554253
PMC: 11143066.
DOI: 10.1007/s15010-024-02223-y.
A Comparison Between Omicron and Earlier COVID-19 Variants' Disease Severity in the Milan Area, Italy.
Consolazio D, Murtas R, Tunesi S, Lamberti A, Senatore S, Faccini M
Front Epidemiol. 2024; 2:891162.
PMID: 38455311
PMC: 10910966.
DOI: 10.3389/fepid.2022.891162.
Heterologous Booster Immunization Based on Inactivated SARS-CoV-2 Vaccine Enhances Humoral Immunity and Promotes BCR Repertoire Development.
Li X, Zeng F, Yue R, Ma D, Meng Z, Li Q
Vaccines (Basel). 2024; 12(2).
PMID: 38400104
PMC: 10891849.
DOI: 10.3390/vaccines12020120.
Factors Associated with SARS-CoV-2 Infection in Fully Vaccinated Nursing Home Residents and Workers.
Mateos-Nozal J, Rodriguez-Dominguez M, San Roman J, Candel F, Villarrubia N, Perez-Panizo N
Viruses. 2024; 16(2).
PMID: 38399962
PMC: 10891794.
DOI: 10.3390/v16020186.
Comparative Analysis of Primary and Monovalent Booster SARS-CoV-2 Vaccination Coverage in Adults with and without HIV in Catalonia, Spain.
Nomah D, Reyes-Uruena J, Alonso L, Diaz Y, Moreno-Fornes S, Aceiton J
Vaccines (Basel). 2024; 12(1).
PMID: 38250857
PMC: 10819920.
DOI: 10.3390/vaccines12010044.
